Biogen Downgraded On Pipeline Setbacks And Leqembi Sales Slowdown If the FDA approves Leqembi subcutaneous maintenance dosing ...

If approved, subcutaneous autoinjector Leqembi will be the only Alzheimer's medication that can be administered at home. The ...

Bruising, redness, itching, pain, or swelling at the injection site may occur. If any of these effects last or get worse, tell your doctor or pharmacist promptly. Remember that this medication has ...

TG Therapeutics expects to report initial data on the subcutaneous form of Briumvi in early 2025. Click here to read why TGTX ...

New Jersey based Antares has signed a deal with pharma giant Pfizer to develop an auto injector pen for ... include Otrexup (methotrexate) subcutaneous injection and the investigational ...

Injection site reactions, such as pain, are common side effects of the medication. Dupixent comes as a single-dose prefilled syringe and pen. You can inject Dupixent as a subcutaneous injection ...

FDA approves the first subcutaneous version of nivolumab, making PD-1 inhibitors available to new groups of patients.

From weight loss to cancer drugs, subcutaneous injections are popular with patients for their convenience, potentially freeing them from cumbersome intravenous infusions. Subcutaneous versions of ...

The FDA has approved nivolumab and hyaluronidase-nvhy for subcutaneous injection in adults with solid tumors in which nivolumab is indicated, according to a press release. Nivolumab and ...

Rising Chronic Diseases: The increasing prevalence of chronic diseases in Vietnam, such as diabetes, rheumatoid arthritis, and multiple sclerosis, has boosted the demand for auto-injectors, which ...